May Fever Trigger Ventricular Fibrillation? by Pasquié, Jean Luc
 
www.ipej.org 139
Point of View
May Fever Trigger Ventricular Fibrillation?
Jean Luc Pasquié, MD, PhD
Hôpital Arnaud de Villeneuve, Montpellier, France.
Address for correspondence: Dr Jean Luc Pasquié, MD, PhD, Hôpital Arnaud de Villeneuve,  
Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. . Email: jl-pasquie@chu-
montpellier.fr
Abstract
               The clinical precipitants of ventricular fibrillation (VF) remain poorly understood. 
Clinical factors such as hypoxemia, acidosis or electrolyte imbalance, drug-related toxicity, 
autonomic nervous system disorders as well as viral myocarditis have been proposed to be 
associated with sudden cardiac death particularly in patients with structural heart disease. 
However, In the Brugada syndrome, concurrent febrile illness has been reported to unmask the 
electrocardiographic features of the Brugada syndrome and be associated with an increased 
propensity for VF. More recently, a febrile illnesses of infectious etiology was associated to 
polymorphic ventricular tachycardia or VF in patients with normal hearts and without known 
repolarization  abnormality.   In   this   review   we   detail   this   phenomenon  and  its   putative 
mechanisms.          
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Introduction
            Ventricular fibrillation (VF) is the main mechanism of sudden cardiac death. Clinical 
factors such as hypoxemia, acidosis or electrolyte imbalance, drug-related toxicity, autonomic 
nervous system disorders as well as viral myocarditis have been proposed to be associated with 
sudden cardiac death particularly in patients with structural heart disease1. Emerging evidence 
implicates triggers dominantly originating from the distal Purkinje arborization and the right 
ventricular outflow tract (RVOT) in the initiation of VF in a range of clinical conditions2-7. 
            Isolated reports in patients with the Brugada syndrome suggest that febrile illnesses may 
unmask the characteristic electrocardiographic changes that then favour the development of VF8-
15. However, the clinical precipitants for VF storms in patients with idiopathic VF, without 
evidence of structural heart disease or known repolarization abnormality, remain poorly 
characterized. Recently we reported a series of patients in whom a febrile illness precipitated 
idiopathic VF storm, suggesting that fever may be a precipitant of sudden cardiac death in 
patients with normal hearts16. 
Fever and Brugada Syndrome
            As summarized in Table 1, isolated case reports have suggested that the phenotypic 
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behaviour of the Brugada syndrome may be influenced by body temperature8-15. These reports 
have observed that not only could the electrocardiographic features of Brugada syndrome 
manifest but also that it may then be associated with VF during concurrent hyperthermia8-15. 
Such presentations with concurrent febrile illness in the literature have all been males between 
the ages of 50 and 70 years. The electrocardiographic features of the Brugada syndrome in each 
case were noted at presentation and gradually returned to normal as fever ceased. However, the 
Brugada electrocardiographic pattern was not reproducible by pharmacologic testing in all 
patients (Table 1). Very recently, ajmaline testing was reported to be a valuable test in diagnosis 
of SCN5A carriers with sensitivity, specificity and positive and negative predictive values of 80, 
94, 93 and 83 % respectively 16. However, considering risk stratification for identifying high-
risk patients in Brugada syndrome, SCN5A mutation, VF inducibility by EP study and 
pharmacologic challenge were not predictive factors of life-threatening arrhythmic events17.   
            Morita et al described a 69 year old patient with prior unexplained resuscitated sudden 
death (5 years ago), who presented with ST segment elevation, T wave alternans and premature 
ventricular contractions in association with a respiratory infection and mild fever (37.5°C)10. In 
two more patients, one with known Brugada syndrome, a febrile illness was associated to 
syncope due to polymorphic ventricular tachycardias or VF8,15. Dinckal and al reported the 
dramatic case of a 55 year old male who experienced fever due to pneumonia which unmasked 
typical ST changes of Brugada syndrome and lead to VF refractory VF storm resulting in the 
patient’s death14. Of particular interest, Mok and colleagues reported the case of a patient whose 
Brugada ECG pattern was unmasked by hyperthermia secondary to acute cholangitis12. In order 
to explain this phenomenon, they have demonstrated by genetic screening a novel mutation in 
the SCN5A gene related to a single amino acid substitution (H681P) confirming the diagnosis of 
Brugada syndrome. This mutation was associated with the loss of transmembrane current and 
induced a pathologic phenotype that may be elicited by hyperthermia12. In vitro expression of 
this amino acid substitution revealed a shift in both steady-state activation and inactivation of 
the sodium channel resulting in a dramatic reduction of sodium window current12. This 
temperature-dependency of ionic mechanisms underlying Brugada syndrome have also been 
described in experimental studies18. They hypothetized that at physiological temperature ranges 
the gating of the sodium channel may be changed by the SCN5A mutation such that the outward 
current is dramatically increased in the early phases of the right ventricular action potential18. 
Using the patch-clamp technique to study the currents at 32° C they tested a missense mutation 
(Thr1620Met) in SCN5A in a mammalian cell line and demonstrated a faster decay and slower 
reactivation of the inward sodium current with a outward shift of the current flowing during 
phase I. This phenomenon may be responsible for a transmural voltage gradient that may cause 
the repolarization abnormalities and be responsible for phase 2 reentry18. This work favours the 
hypothesis that some mutations may exhibit temperature-dependency properties and may 
explain that some patients may be at particularly high risk during febrile illnesses18,19. 
    
Fever and Idiopathic Ventricular Fibrillation
            In contrast, a paucity of reports (Table 1) describes association of fever and ventricular 
fibrillation   in   patients   with   idiopathic   VF.   Unlike   other   polymorphic   ventricular 
tachyarrhythmias, idiopathic VF is generally not related to stress20, anger or physical activity21 
and spontaneous VF in these patients is initiated by premature ventricular complexes with very 
short coupling intervals22. 
            In patients with structural heart disease, the clinical factors that may be associated with 
ventricular fibrillation are transient ischemia and reperfusion, systemic factors as hypoxemia, 
acidosis or electrolyte imbalance, neurophysiologic interactions or toxic effects1.  In patients 
with  normal  hearts,  viral  myocarditis  is  generally  considered one of the main mechanism of 
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sudden cardiac death associated with a febrile illness; although this has been poorly documented 
and could only be demonstrated by biopsy. We recently reported 3 patients who had no 
demonstrable structural heart disease or repolarization abnormalities and who presented with 
episodes of VF storm during a peak of a febrile illness usually occurring at night23.  They 
demonstrated short coupled ventricular ectopies (Fig 1). Ectopy morphology was highly 
suggestive of left Purkinje origin in one, and of muscular origin from RVOT in the other one. In 
the third patient with recurrent episodes of VF, mapping and ablation was performed confirming 
the origin of the triggering ectopy from the right Purkinje system (Fig 2). None of our patients 
had evidence to suggest a viral myocarditis with biological screens, troponin values and viral 
screens being normal. In addition, one of these patients had a documented bacterial urinary 
sepsis. A potential role for the autonomic nervous system cannot be excluded as VF occurred at 
night; however, none of our patients demonstrated a change in repolarization prior to VF storm.
Table 1:  Reports of Fever in patients with Brugada syndrome or Idiopathic 
ventricular fibrillation. 
            The distal Purkinje arborization has been implicated as the site of origin of triggers 
initiating VF in a variety of clinical situations. These include patients with VF associated with 
structural heart disease such as following myocardial infarction7  abnormal repolarization 
syndromes4 and also those with idiopathic VF2,3. The Purkinje system while being capable of 
sustaining spontaneous activity by automaticity, reentry or triggered activity, is known to be 
sensitive to a variety of clinical situations. The similarity of these observations with those made 
in the Brugada syndrome, indicates a potentially greater role of concurrent illnesses in the 
initiation of VF. Indeed, heterogeneous changes in ion-channel expression have been described 
in Purkinje fibers and ventricular muscle in experimental studies24 Taken in conjunction with 
our findings25, it indicates a potentially greater role of such concurrent illnesses in the initiation 
of VF. The morphologic features of the short coupled ectopy in the three febrile patients with 
normal hearts were identical to those previously demonstrated in patients with idiopathic VF22. 
The similar origin of triggers in this series suggests that the current observations may have 
resulted from increased frequency or malignancy of the triggers by the febrile illness in these 
patients with idiopathic VF. This series provides new information on the precipitating role of 
concurrent febrile illness in the initiation of VF in patients with normal hearts. A possible Jean 
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explanation is that some patients may exhibit temperature-dependent modifications of ion 
channel properties or expression that may facilitate spontaneous activity within Purkinje or 
RVOT as a potential mechanism for these observations.
Figure 1: Polymorphic ventricular tachycardia initiated by short coupling ectopy 
in a 58  year old patient with febrile urinary sepsis and repetitive syncope. Further 
monitoring of this patient exhibited syncope related to ventricular fibrillation 
necessitating cardioversion. 
Conclusion:
            Febrile illness is a common clinical situation managed by a variety of physicians. From 
the data available so far, it appears that an apparently benign febrile illness may be associated 
with malignant ventricular arrhythmias in patients with Brugada syndrome and sometimes in the 
absence of cardiac disease or other factors known to precipitate sudden cardiac death. The 
mechanism is still unclear but may be related to temperature-dependent modifications of ion 
channel properties or expression that facilitate spontaneous activity within Purkinje or RVOT as 
triggers of ventricular fibrillation. We believe that physicians should be aware of this possible 
phenomenon in all cases of febrile illness associated with syncope.
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Figure 2: Sharp Purkinje potential preceding the initiating ventricular ectopy in 
the same patient
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